Archived Grant Opportunity View - GO5828
MRFF 2022 Rapid Applied Research Translation Grant Opportunity
Show close time for other time zones
The 2022 Rapid Applied Research Translation Grant Opportunity is part of the Medical Research Future Fund and the Rapid Applied Research Translation Initiative.
This initiative is investing in research projects that encourage academic researchers and health service providers to collaborate to improve health care delivery, services and systems sustainability.
Three streams of funding are available.
Streams 1 and 2 - Accelerator
These streams aim to support Australian medical research and medical innovation projects that:
- use existing knowledge to support and accelerate the translation of research findings into improved health care and health interventions, that have the potential for broader applicability
- address a clearly defined gap in the implementation of best practice health care and health interventions to improve health outcomes
- involve all stakeholders relevant to the research and its translation in its conceptualisation, design and implementation, including health care consumers and providers.
For Stream 2, funding is available to eligible organisations based in rural areas (MM2-7 location according to the Modified Monash Model Locator).
Stream 3 - Targeted Call for Research
This stream aims to support a medical research project that:
- prospectively evaluates all projects funded through the 2022 Rapid Applied Research Translation grant opportunity, as well as grants awarded through the previous 2020 Rapid Applied Research Translation grant opportunity
- generates knowledge that improves understanding of the factors that promote the adoption, impact and sustainability of evidence-based practice in health care.
Eligible organisations can submit a maximum of one application to either Stream 1 or Stream 2 and/or Stream 3.
You can apply if you:
- have an Australian Business Number (ABN)
- are incorporated in Australia
and in accordance with s24 of the MRFF Act 2015, are one of the following entities:
- a medical research institute
- a university
- a corporate Commonwealth entity
- a corporation (including businesses and not for profits).
Under Stream 2:
- the lead organisation must be located within an MM2-7 location
- your Chief Investigator A and more than 50% of all Chief Investigators must be primarily resident in an MM2-7 location.
We can only accept applications where you can provide:
- evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
- letters of support from each project partner, where applicable.
You can’t apply if you are a/an:
- unincorporated association
- trust (however, an incorporated trustee may apply on behalf of a trust)
- non-corporate Commonwealth entity
- organisation, or your project partner is an organisation, included on the National Redress Scheme’s list of Institutions that have not joined or signified their intent to join the Scheme
- employer of 100 or more employees that has not complied with the Workplace Gender Equality Act 2012.
Partner with other organisations
Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply.
The lead organisation must fill out the application form.
If we give your group a grant, the lead organisation:
- signs the grant agreement
- is responsible for making sure your group follows the rules in the grant agreement.
To apply, go to: www.business.gov.au/2022-RART
business.gov.au provides information and advice to customers via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.